CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Dong-E-E-Jiao Co Ltd Company Snapshot
Dong-E-E-Jiao Co Ltd operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Dong-E-E-Jiao Co Ltd with three other companies in this sector in CHINA : Sunflower Pharmaceutical Group Co Ltd (2020 sales of 3.46 billion Chinese Renmimbi [US$534.06 million] of which 168% was Medicine), Guizhou Yibai Pharmaceutical Co., Ltd. (3.41 billion Chinese Renmimbi [US$526.66 million] of which 87% was Medical Industry), and Gan & Lee Pharmaceuticals Co Ltd (3.36 billion Chinese Renmimbi [US$518.74 million] of which 98% was Biological products).

Sales Analysis. Sales were up sharply during the first quarter of 2021 versus the previous year's first quarter. During the first quarter of 2021, sales at Dong-E-E-Jiao Co Ltd totalled 722.41 million Chinese Renmimbi. This is an increase of 62.6% from the 444.22 million Chinese Renmimbi in sales at the company during the first quarter of 2020. There appears to be at least some degree of seasonality in the sales at Dong-E-E-Jiao Co Ltd: during 8 of the previous 9 years, sales were highest during the fourth quarter. The exception to this was during 2019, when the first quarter was the best quarter, accounting for 44% of sales (during that same year, the fourth quarter accounted for 4% of sales). Dong-E-E-Jiao Co Ltd reported sales of 3.41 billion Chinese Renmimbi (US$525.85 million) for the year ending December of 2020. This represents an increase of 15.0% versus 2019, when the company's sales were 2.96 billion Chinese Renmimbi. Despite this increase, sales are still well below the level achieved in 2018, when Dong-E-E-Jiao Co Ltd reported sales of 7.34 billion Chinese Renmimbi. Sales of Pharmaceutical Industry saw an increase that was more than double the company's growth rate: sales were up 45.1% in 2020, from 2.07 billion Chinese Renmimbi to 3.00 billion Chinese Renmimbi. Not all segments of Dong-E-E-Jiao Co Ltd experienced an increase in sales in 2020: sales of Other fell 87.2% to 111.02 million Chinese Renmimbi.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Dong-E-E-Jiao Co Ltd
  Stock Performance Chart for Dong-E-E-Jiao Co Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (6/18/2021): 34.24
(Figures in Chinese Renmimbi)
1 Week -4.1%   13 Weeks -1.1%  
4 Weeks -5.7%   52 Weeks -5.3%  
 
Dong-E-E-Jiao Co Ltd Key Data:
  Ticker: 000423 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2020 Sales 3,407,993,863
(Year Ending Jan 2021).
Employees: 4,509
  Currency: Chinese Renmimbi Market Cap: 22,393,697,427
  Fiscal Yr Ends: December Shares Outstanding: 654,021,537
  Share Type: A Gu Closely Held Shares: 232,255,606
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.